Pfizer's Hympavzi meets key phase III goals, demonstrating a significant reduction in bleeding in hemophilia patients with ...

M3GAN 2.0 takes that tradition to terrifying new extremes, particularly thanks to the unforgettable presence of Amelia. As ...

Preventive treatment with Pfizer's Hympavzi can reduce bleeding rates in hemophilia A or B patients with inhibitors, new ...

In “Sick and Dirty,” author Michael Koresky takes a clear-eyed look at golden age Hollywood’s stealth queerness on screen.

Justin Tucker, one of the best kickers in NFL history, suspended for 10 weeks after 16 women said he was sexually ...

Pfizer has reported positive topline outcomes from the multicentre, open-label Phase III BASIS trial of Hympavzi (marstacimab ...

The Democrat will be the first woman and one of fewer than 20 Minnesotans accorded the honor. She will lie in state with her ...

GAINESVILLE, Fla. (WCJB) - Florida Congresswoman Kat Cammack’s Gainesville and Ocala offices remain temporarily closed ...

Topline data were announced from a phase 3 trial evaluating marstacimab for adults and adolescents living with hemophilia A or B with inhibitors.

Pfizer's Hympavzi showed superior bleed control in hemophilia A and B patients with inhibitors, reducing bleeding rates and ...

Approved eight months ago for a certain class of patients with both hemophilia A or B, Pfizer’s Hympavzi has now shown its ...

Pfizer's hemophilia therapy, Hympavzi, met the main goal of a late-stage study in patients with certain types of antibodies, ...